Cargando…
Non-High-Risk Neuroblastoma: Classification and Achievements in Therapy
Neuroblastoma, a tumor of the sympathetic nervous system, is the most common extra-cranial neoplasm of childhood. Variables with prognostic significance in patients with neuroblastoma, including age at diagnosis, disease stage, tumor histology, MYCN gene amplification, tumor cell ploidy, and the pre...
Autor principal: | Meany, Holly J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6352142/ https://www.ncbi.nlm.nih.gov/pubmed/30626019 http://dx.doi.org/10.3390/children6010005 |
Ejemplares similares
-
The Evolution of Risk Classification for Neuroblastoma
por: Sokol, Elizabeth, et al.
Publicado: (2019) -
Monoclonal Antibody Therapies for High Risk Neuroblastoma
por: Furman, Wayne L
Publicado: (2021) -
Association of high-risk neuroblastoma classification based on expression profiles with differentiation and metabolism
por: Kimura, Shunsuke, et al.
Publicado: (2021) -
MIBG Therapy for Neuroblastoma: Precision Achieved With Dosimetry, and Concern for False Responders
por: Rubio, Pedro M., et al.
Publicado: (2020) -
Patterns of recurrence after radiation therapy for high-risk neuroblastoma
por: Jo, Ji Hwan, et al.
Publicado: (2019)